We used ChIP to investigate the extent of H3Ac and H3K4me3 marking associated with the PRKCB promoter in CLL and normal B cells, focussing on the region of DNA containing the SP1 binding sites (Fig. 4a and b). This evidence concerns the gene PRKCB and B-cell chronic lymphocytic leukemia.